Dopamine D 1-like receptors regulate the 1 A-adrenergic receptor in human renal proximal tubule cells and D 1-like dopamine receptor knockout mice

Riley Charles Ennis, Laureano D. Asico, Ines Armando, Jian Yang, Jun B. Feranil, Julie A. Jurgens, Crisanto S. Escano, Jr., Peiying Yu, Xiaoyan Wang, David R. Sibley, Pedro A. Jose, and Van Anthony M. Villar Thomas Jefferson High School for Science and Technology, Alexandria, Virgina; Division of Nephrology, Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland; Molecular Neuropharmacology Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland; Department of Physiology, University of Maryland School of Medicine, Baltimore, Maryland

[1]  Shuo Zheng,et al.  Gastrin and D1 Dopamine Receptor Interact to Induce Natriuresis and Diuresis , 2013, Hypertension.

[2]  V. A. Villar,et al.  Novel role of sorting nexin 5 in renal D1 dopamine receptor trafficking and function: implications for hypertension , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[3]  V. A. Villar,et al.  Sorting Nexin 1 Loss Results in D5 Dopamine Receptor Dysfunction in Human Renal Proximal Tubule Cells and Hypertension in Mice* , 2012, The Journal of Biological Chemistry.

[4]  J. Yatabe,et al.  Dopamine and Angiotensin Type 2 Receptors Cooperatively Inhibit Sodium Transport in Human Renal Proximal Tubule Cells , 2012, Hypertension.

[5]  S. Weinbaum,et al.  Regulation of glomerulotubular balance. I. Impact of dopamine on flow-dependent transport. , 2012, American journal of physiology. Renal physiology.

[6]  R. Harris,et al.  Dopamine, the Kidney, and Hypertension , 2012, Current Hypertension Reports.

[7]  T. Coffman,et al.  The kidney and hypertension: novel insights from transgenic models , 2012, Current opinion in nephrology and hypertension.

[8]  Francesco Amenta,et al.  Dopamine and vascular dynamics control: present status and future perspectives. , 2011, Current neurovascular research.

[9]  V. A. Villar,et al.  Dopamine and renal function and blood pressure regulation. , 2011, Comprehensive Physiology.

[10]  D. Sibley,et al.  Upregulation of Renal Sodium Transporters in D5 Dopamine Receptor–Deficient Mice , 2010, Hypertension.

[11]  J. Docherty.  Subtypes of functional α1-adrenoceptor , 2010, Cellular and Molecular Life Sciences.

[12]  I. Armando,et al.  Renal dopaminergic defect in C57Bl/6J mice. , 2009, American journal of physiology. Regulatory, integrative and comparative physiology.

[13]  R. Felder,et al.  Caveolin-1 and Dopamine-Mediated Internalization of NaKATPase in Human Renal Proximal Tubule Cells , 2009, Hypertension.

[14]  S. Shenolikar,et al.  Signaling pathways utilized by PTH and dopamine to inhibit phosphate transport in mouse renal proximal tubule cells. , 2009, American journal of physiology. Renal physiology.

[15]  D. Sibley,et al.  Reciprocal Modulation of Function between the D1 and D2 Dopamine Receptors and the Na+,K+-ATPase* , 2008, Journal of Biological Chemistry.

[16]  L. Scott,et al.  Negative reciprocity between angiotensin II type 1 and dopamine D1 receptors in rat renal proximal tubule cells. , 2008, American journal of physiology. Renal physiology.

[17]  V. A. Villar,et al.  Dopamine, kidney, and hypertension: studies in dopamine receptor knockout mice , 2008, Pediatric Nephrology.

[18]  R. Felder,et al.  Lipid Rafts Keep NADPH Oxidase in the Inactive State in Human Renal Proximal Tubule Cells , 2008, Hypertension.

[19]  A. Ciechanover,et al.  Phosphorylation and ubiquitination are necessary for Na,K-ATPase endocytosis during hypoxia. , 2007, Cellular signalling.

[20]  Q. Han,et al.  Receptor subtype involved in α1-adrenergic receptor-mediated Ca2+ signaling in cardiomyocytes , 2007, Acta Pharmacologica Sinica.

[21]  C. Pedemonte,et al.  Contrary to rat-type, human-type Na,K-ATPase is phosphorylated at the same amino acid by hormones that produce opposite effects on enzyme activity. , 2005, Journal of the American Society of Nephrology : JASN.

[22]  S. Tyagi,et al.  Reduced alpha adrenergic mediated contraction of renal preglomerular blood vessels as a function of gender and aging , 2005, Journal of cellular biochemistry.

[23]  R. Felder,et al.  Rat Strain Effects of AT1 Receptor Activation on D1 Dopamine Receptors in Immortalized Renal Proximal Tubule Cells , 2005, Hypertension.

[24]  A. Bertorello,et al.  Inhibition of Na,K-ATPase by dopamine in proximal tubule epithelial cells. , 2005, Seminars in nephrology.

[25]  Daniel Bernstein,et al.  The mouse as a model of cardiovascular adaptations to microgravity. , 2004, Journal of applied physiology.

[26]  J. Kehr,et al.  The Role of α1- and α2-Adrenoreceptors on Venlafaxineinduced Elevation of Extracellular Serotonin, Noradrenaline and Dopamine Levels in the Rat Prefrontal Cortex and Hippocampus , 2004 .

[27]  Marco Cosentino,et al.  Dopaminergic D1-like receptor-dependent inhibition of tyrosine hydroxylase mRNA expression and catecholamine production in human lymphocytes. , 2004, Biochemical pharmacology.

[28]  R. Felder,et al.  Production and Role of Extracellular Guanosine Cyclic 3′, 5′ Monophosphate in Sodium Uptake in Human Proximal Tubule Cells , 2004, Hypertension.

[29]  M. Katsuki,et al.  Dopamine D2 Receptor Modulates Sodium Handling via Local Production of Dopamine in the Kidney , 2003, Journal of cardiovascular pharmacology.

[30]  B. Kaissling,et al.  Dopamine acutely decreases apical membrane Na/H exchanger NHE3 protein in mouse renal proximal tubule. , 2003, Kidney international.

[31]  M. Katsuki,et al.  Disruption of the type 2 dopamine receptor gene causes a sodium-dependent increase in blood pressure in mice. , 2003, American journal of hypertension.

[32]  H. Rockman,et al.  Dual Inhibition of &bgr;-Adrenergic and Angiotensin II Receptors by a Single Antagonist: A Functional Role for Receptor–Receptor Interaction In Vivo , 2003, Circulation.

[33]  C. Muro-Cacho,et al.  Activation of α1-adrenergic receptors potentiates the nephrotoxicity of ethylene dibromide , 2003 .

[34]  D. Sibley,et al.  Mice Lacking D5 Dopamine Receptors Have Increased Sympathetic Tone and Are Hypertensive , 2002, The Journal of Neuroscience.

[35]  P. Soares-da-Silva,et al.  Dopamine-induced inhibition of Na+-K+-ATPase activity requires integrity of actin cytoskeleton in opossum kidney cells. , 2002, Acta physiologica Scandinavica.

[36]  D. Grandy,et al.  Adrenergic and Endothelin B Receptor-Dependent Hypertension in Dopamine Receptor Type-2 Knockout Mice , 2001, Hypertension.

[37]  F. Liu,et al.  alpha(1)-Adrenergic receptors activate NHE1 and NHE3 through distinct signaling pathways in epithelial cells. , 2001, American journal of physiology. Renal physiology.

[38]  T. Pressley,et al.  Simultaneous phosphorylation of Ser11 and Ser18 in the alpha-subunit promotes the recruitment of Na(+),K(+)-ATPase molecules to the plasma membrane. , 2000, Biochemistry.

[39]  W. Simonds,et al.  Regulation of NHE3 activity by G protein subunits in renal brush-border membranes. , 2000, American journal of physiology. Regulatory, integrative and comparative physiology.

[40]  T. Macedo,et al.  Presynaptic dopamine receptors involved in the inhibition of noradrenaline and dopamine release in the human gastric and uterine arteries , 1999, Fundamental & clinical pharmacology.

[41]  T. Svensson,et al.  Enhanced cortical dopamine output and antipsychotic-like effects of raclopride by alpha2 adrenoceptor blockade. , 1999, Science.

[42]  Y. Hayashi,et al.  Renal nerve stimulation induces alpha2-adrenoceptor-mediated antinatriuresis under inhibition of prostaglandin synthesis in anesthetized dogs. , 1999, The Tohoku journal of experimental medicine.

[43]  D. Bruns,et al.  Dopamine-1 receptor coupling defect in renal proximal tubule cells in hypertension. , 1999, Hypertension.

[44]  Nasu,et al.  Distribution of α1‐adrenoceptor subtype mRNAs in human renal cortex , 1999 .

[45]  P. Berggren,et al.  Dopamine-induced Endocytosis of Na+,K+-ATPase Is Initiated by Phosphorylation of Ser-18 in the Rat α Subunit and Is Responsible for the Decreased Activity in Epithelial Cells* , 1999, The Journal of Biological Chemistry.

[46]  M. Baum,et al.  Inhibition of proximal convoluted tubule transport by dopamine. , 1998, Kidney international.

[47]  A. Aperia,et al.  Cellular mechanisms for bi-directional regulation of tubular sodium reabsorption. , 1996, Kidney international.

[48]  D. Sibley,et al.  Role of the D1A dopamine receptor in the pathogenesis of genetic hypertension. , 1996, The Journal of clinical investigation.

[49]  M. Lisanti,et al.  Co-purification and Direct Interaction of Ras with Caveolin, an Integral Membrane Protein of Caveolae Microdomains , 1996, The Journal of Biological Chemistry.

[50]  P. Goldman-Rakic,et al.  Characterization of subtype-specific antibodies to the human D5 dopamine receptor: studies in primate brain and transfected mammalian cells. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[51]  P. Soares-da-Silva.  Renal tubular dopamine outward transfer during Na+‐H+ exchange activation by α1‐ and α2‐adrenoceptor agonists , 1993 .

[52]  R. Felder,et al.  D1A dopamine receptor stimulation inhibits Na+/K(+)-ATPase activity through protein kinase A. , 1993, Molecular pharmacology.

[53]  P. Ho,et al.  Proximal tubular dopamine production regulates basolateral Na-K-ATPase. , 1992, The American journal of physiology.

[54]  A. Sidhu.  A novel affinity purification of D-1 dopamine receptors from rat striatum. , 1990, The Journal of biological chemistry.

[55]  F. Gesek,et al.  Synergistic alpha-1 and alpha-2 adrenergic stimulation of rat proximal nephron Na+/H+ exchange. , 1989, The Journal of pharmacology and experimental therapeutics.

[56]  R. Graham,et al.  Glycosylation of the mammalian alpha 1-adrenergic receptor by complex type N-linked oligosaccharides. , 1987, Molecular pharmacology.

[57]  A. Baines.  Effects of salt intake and renal denervation on catecholamine catabolism and excretion. , 1982, Kidney international.

[58]  R. Schrier,et al.  Catecholamines and sodium transport in the kidney. , 1979, Pharmacological reviews.

[59]  D. Harrison.  The mosaic theory revisited: common molecular mechanisms coordinating diverse organ and cellular events in hypertension. , 2013, Journal of the American Society of Hypertension : JASH.

[60]  H. Ren,et al.  Inhibitory effect of D 1-like and D 3 dopamine receptors on norepinephrine-induced proliferation in vascular smooth muscle cells , 2008 .

[61]  P. Insel,et al.  G-protein-coupled receptor-signaling components in membrane raft and caveolae microdomains. , 2008, Handbook of experimental pharmacology.

[62]  A. Aperia.  Intrarenal dopamine: a key signal in the interactive regulation of sodium metabolism. , 2000, Annual review of physiology.

[63]  F. Gesek.  Alpha1- and alpha2-adrenoceptor control of sodium transport reverses in developing hypertension. , 1999, Hypertension.

[64]  R. Felder,et al.  Effects of costimulation of dopamine D1- and D2-like receptors on renal function. , 1998, The American journal of physiology.

[65]  K. Geering,et al.  Adrenergic, dopaminergic, and muscarinic receptor stimulation leads to PKA phosphorylation of Na-K-ATPase. , 1996, The American journal of physiology.

[66]  M. Lokhandwala,et al.  Alpha 1-adrenoceptor subtypes mediating stimulation of Na+,K(+)-ATPase activity in rat renal proximal tubules. , 1995, European journal of pharmacology.

[67]  L. Svensson,et al.  Calcineurin mediates a-adrenergic stimulation ofNa+,K+-ATPase activity inrenal tubule cells , 1992 .